1. Acknowledgement

   Acknowledgement 12 October 2012 Pages: 765 - 766

2. Pharmacodynamic Models for Discrete Data

   • Ines Paule
   • Pascal Girard
   • Michel Tod

   Review Article 17 October 2012 Pages: 767 - 786

   

3. Population Pharmacokinetic Analysis during the First 2 Years of Life

   • Amélie Marsot
   • Audrey Boulamery
   • Nicolas Simon

   Review Article 16 October 2012 Pages: 787 - 798

   

4. Inter-Individual Differences in Baseline Coagulation Activities and Their Implications for International Normalized Ratio Control During Warfarin Initiation Therapy

   • Yosuke Ichimura
   • Harumi Takahashi
   • Hirotoshi Echizen

   Original Research Article 13 September 2012 Pages: 799 - 808

   

5. Pharmacokinetic Modelling of Efavirenz, Atazanavir, Lamivudine and Tenofovir in the Female Genital Tract of HIV-Infected Pre-Menopausal Women

   • Julie B. Dumond
   • Melanie R. Nicol
   • Angela D. M. Kashuba

   Original Research Article 09 October 2012 Pages: 809 - 822

   

6. Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

   • Philippe Moreau
   • Ievgenii I. Karamanesht
   • Thierry Facon

   Original Research Article 25 September 2012 Pages: 823 - 829

   

7. Erratum to: Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors

   • Larry K. Golightly
   • Caitlin C. Drayna
   • Michael T. McDermott

   Erratum 09 November 2012 Pages: 831 - 831